U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 30

Tests names and labsConditionsGenes, analytes, and microbesMethods

Detection of the G2019S mutation in exon 41 of the LRRK2 gene

Neurogenetics Cyprus Institute of Neurology and Genetics
Cyprus
11
  • T Targeted variant analysis

LRRK2 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoNeuro Panel

Centogene AG - the Rare Disease Company
Germany
18861858
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Parkinson Disease Panel

Centogene AG - the Rare Disease Company
Germany
7876
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Hereditary Parkinson Disease and Parkinsonism Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
4426
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Parkinson disease 8, 607060, Autosomal dominant; PARK8 (Hereditary late-onset Parkinson disease) (LRRK2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Parkinson disease

IU Genetic Testing Laboratories Indiana University School of Medicine
United States
11
  • T Targeted variant analysis

Parkinson Disease and Parkinsonism Panel

PreventionGenetics, part of Exact Sciences
United States
7071
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Parkinson Disease via the LRRK2 Gene

PreventionGenetics, part of Exact Sciences
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Parkinson Disease Panel

PreventionGenetics, part of Exact Sciences
United States
2724
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

LRRK2 Single Gene Analysis

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
11
  • C Sequence analysis of the entire coding region

LRRK2 MLPA

Institute for Human Genetics University Medical Center Freiburg
Germany
11
  • D Deletion/duplication analysis

Parkinson's disease panel. NGS panel of 22 genes.

Genologica Medica
Spain
4522
  • C Sequence analysis of the entire coding region

Parkinson Type 8, LRRK2

Duzen Laboratories Duzen BBAGUAS
Turkey
11
  • C Sequence analysis of the entire coding region

Parkinson deletion/duplication analysis

Duzen Laboratories Duzen BBAGUAS
Turkey
88
  • D Deletion/duplication analysis

Parkinson Disease: Full gene sequencing panel

CEN4GEN Institute for Genomics and Molecular Diagnostics
Canada
2024
  • C Sequence analysis of the entire coding region

PARKINSON TYPE 8 (PARK8)

Laboratorio de Genetica Clinica SL
Spain
10
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

LRRK2 DNA Test

Athena Diagnostics
United States
11
  • E Sequence analysis of select exons

Parkinson disease type 8

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Single gene testing LRRK2

CeGaT GmbH
Germany
11
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 30

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.